Hyper-CVAD regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hyper-CVAD regimen, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias [Phase 1]